Aligos Therapeutics, Inc.
ALGS
Revenue
606.00k
▼-644.00k▼-51.52%
3 Months ChangeAssets
70.09M
▼-18.33M▼-20.73%
3 Months ChangeLiabilities
99.07M
▲60.74M▲158.46%
3 Months ChangeFree Cash Flow
-22.39M
▼-1.45M▼-6.90%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-05
Form 8-K
ID: 0001193125-24-214188
2024-08-19
Form 8-K
ID: 0001193125-24-202813
2024-08-08
Form 8-K
ID: 0001193125-24-196966
2024-08-06
Form 10-Q
ID: 0000950170-24-091828
2024-08-06
Form 8-K
ID: 0001171843-24-004482
2024-06-28
Form 8-K
ID: 0001193125-24-172218
2024-05-31
Form 8-K
ID: 0001193125-24-151729
2024-05-22
Form 8-K
ID: 0001193125-24-144929
2024-05-15
Form 8-K
ID: 0001193125-24-139476
2024-05-07
Form 10-Q
ID: 0000950170-24-054497